View full meeting coverage »

Eyetube Meeting Coverage:

2018 American Society of Retina Specialists Annual Meeting

 

Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

Highlights From the Phase 3 Chroma and Spectri Trials

  Channels: Retina | Posted 7/20/2018

Carl D. Regillo, MD, FACS, analyzes data from the Chroma and Spectri phase 3 lampalizumab (Roche/Genentech) trials with regard to the effect of baseline characteristics on the progression of geographic atrophy.

ASRS Vancouver 2018 • lampalizumab


15 / 17 Series: 2018 American Society of Retina Specialists Annual Meeting